Claude Perreault focuses on Major histocompatibility complex, Immunology, MHC class I, Minor histocompatibility antigen and Repertoire. He interconnects Antigen presentation and Cell biology in the investigation of issues within Major histocompatibility complex. His Proteasome study in the realm of Cell biology connects with subjects such as Neoplastic transformation.
His Immunology research is multidisciplinary, relying on both Cytotoxic T cell and Graft-versus-host disease. Graft-versus-host disease is a subfield of Transplantation that Claude Perreault tackles. His MHC class I study incorporates themes from Transcriptome, Proteomics, Information retrieval and Gene expression profiling.
Claude Perreault mainly investigates Immunology, Cell biology, Major histocompatibility complex, Cytotoxic T cell and Antigen. His research integrates issues of Transplantation and Graft-versus-host disease in his study of Immunology. His study looks at the intersection of Cell biology and topics like Transcriptome with Biogenesis.
In general Major histocompatibility complex study, his work on MHC class I often relates to the realm of Repertoire, thereby connecting several areas of interest. As part of the same scientific family, he usually focuses on Cytotoxic T cell, concentrating on CD8 and intersecting with Molecular biology. Claude Perreault combines subjects such as Cancer research, Immune system and Cancer immunotherapy with his study of Antigen.
Claude Perreault mainly investigates Major histocompatibility complex, Antigen, Computational biology, Cell biology and Cancer research. His research in Major histocompatibility complex intersects with topics in Transcriptome and Human genome. The study incorporates disciplines such as Cancer cell, Cytotoxic T cell, Immune system and Cancer immunotherapy in addition to Antigen.
Immune system is the subject of his research, which falls under Immunology. His research investigates the connection between Immunology and topics such as Hematopoietic stem cell transplantation that intersect with problems in Calcineurin. His Cell biology research includes themes of RNA, Cell, Gene expression and CD8.
Claude Perreault mostly deals with Major histocompatibility complex, Antigen, Cell biology, Computational biology and Immune system. His primary area of study in Major histocompatibility complex is in the field of MHC class I. The concepts of his Antigen study are interwoven with issues in Cancer research, Proteogenomics and Cancer immunotherapy.
His Cell biology study combines topics in areas such as Acute Thymic Involution, Stromal cell and Transcriptome. Claude Perreault has researched Computational biology in several fields, including Open reading frame, Gene, Minor histocompatibility antigen and Peptide. His Immune system research incorporates elements of Cancer cell, Autophagy and Programmed cell death.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Development of a highly polymorphic STR marker for identity testing purposes at the human androgen receptor gene (HUMARA).
Danielle Desmarais;Yixi Zhong;Ranajit Chakraborty;Claude Perreault.
Journal of Forensic Sciences (1998)
Noncoding regions are the main source of targetable tumor-specific antigens
Céline M. Laumont;Krystel Vincent;Leslie Hesnard;Éric Audemard.
Science Translational Medicine (2018)
A comprehensive map of the mTOR signaling network.
Etienne Caron;Samik Ghosh;Yukiko Matsuoka;Dariel Ashton‐Beaucage.
Molecular Systems Biology (2010)
Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease
Pierre Fontaine;Guillaume Roy-Proulx;Laurent Knafo;Chantal Baron.
Nature Medicine (2001)
The MHC class I peptide repertoire is molded by the transcriptome
Marie-Hélène Fortier;Étienne Caron;Marie-Pierre Hardy;Grégory Voisin.
Journal of Experimental Medicine (2008)
Minor histocompatibility antigens
C Perreault;F Decary;S Brochu;M Gyger.
Blood (1990)
MHC class I–associated peptides derive from selective regions of the human genome
Hillary Pearson;Tariq Daouda;Diana Paola Granados;Chantal Durette.
Journal of Clinical Investigation (2016)
Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames.
Céline M. Laumont;Tariq Daouda;Jean-Philippe Laverdure;Éric Bonneil.
Nature Communications (2016)
A granulocyte-macrophage colony–stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties
Moutih Rafei;Jeremy Hsieh;Simone Zehntner;Simone Zehntner;MengYang Li.
Nature Medicine (2009)
The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection
Mélanie Dieudé;Christina Bell;Julie Turgeon;Deborah Beillevaire.
Science Translational Medicine (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Montreal
University of Montreal
University of Wisconsin–Madison
University of Montreal
University of Montreal
University of Oulu
University of Montreal
Tufts University
Sorbonne University
Harvard University
General Atomics (United States)
Ludwig-Maximilians-Universität München
Shanghai University
University of Colorado Boulder
National Research Council Canada
Odense University Hospital
Medical University of Vienna
Independent Scientist / Consultant, US
Claude Bernard University Lyon 1
University at Albany, State University of New York
University of Alicante
University of Helsinki
National Institutes of Health
Newcastle University
University of British Columbia
Stanford University